---
schema_version: "secwatch.filing_event.v1"
accession: "0001664710-25-000010"
form_type: "8-K"
ticker: "KROS"
cik: "0001664710"
company_name: "Keros Therapeutics, Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:34:44.008972+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Keros CEO Jasbir Seehra to present at Guggenheim SMID Cap Biotech Conference on Feb 6

## Summary
- Chair and CEO Jasbir Seehra will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference.
- Presentation scheduled for Thursday, February 6, 2025, at 10:00 a.m. Eastern time.
- Live webcast and 90-day replay available via Keros investor relations page.

## SEC filing metadata
- accession: 0001664710-25-000010
- form_type: 8-K
- ticker: KROS
- cik: 0001664710
- company_name: Keros Therapeutics, Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1664710/000166471025000010/0001664710-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1664710/000166471025000010/kros-20250130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001664710-25-000010
- JSON: https://secwatch.observer/filing/0001664710-25-000010.json
- Plain text: https://secwatch.observer/filing/0001664710-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.